Urothelial  ||| S:0 E:11 ||| JJ
carcinoma  ||| S:11 E:21 ||| NN
in  ||| S:21 E:24 ||| IN
bladder  ||| S:24 E:32 ||| JJ
diverticula ||| S:32 E:43 ||| NN
:  ||| S:43 E:45 ||| :
outcomes  ||| S:45 E:54 ||| NNS
after  ||| S:54 E:60 ||| IN
radical  ||| S:60 E:68 ||| JJ
cystectomy  ||| S:68 E:79 ||| NN
To  ||| S:79 E:82 ||| TO
characterize  ||| S:82 E:95 ||| VB
the  ||| S:95 E:99 ||| DT
clinical  ||| S:99 E:108 ||| JJ
and  ||| S:108 E:112 ||| CC
pathologic  ||| S:112 E:123 ||| JJ
staging  ||| S:123 E:131 ||| NN
of  ||| S:131 E:134 ||| IN
patients  ||| S:134 E:143 ||| NNS
with  ||| S:143 E:148 ||| IN
urothelial  ||| S:148 E:159 ||| JJ
carcinoma  ||| S:159 E:169 ||| NNS
( ||| S:169 E:170 ||| -LRB-
UC ||| S:170 E:172 ||| NNP
)  ||| S:172 E:174 ||| -RRB-
in  ||| S:174 E:177 ||| IN
bladder  ||| S:177 E:185 ||| JJ
diverticula  ||| S:185 E:197 ||| NNS
( ||| S:197 E:198 ||| -LRB-
BD ||| S:198 E:200 ||| NNP
)  ||| S:200 E:202 ||| -RRB-
after  ||| S:202 E:208 ||| IN
undergoing  ||| S:208 E:219 ||| VBG
radical  ||| S:219 E:227 ||| JJ
cystectomy  ||| S:227 E:238 ||| NNS
( ||| S:238 E:239 ||| -LRB-
RC ||| S:239 E:241 ||| NNP
)  ||| S:241 E:243 ||| -RRB-
and  ||| S:243 E:247 ||| CC
determine  ||| S:247 E:257 ||| VB
the  ||| S:257 E:261 ||| DT
impact  ||| S:261 E:268 ||| NN
of  ||| S:268 E:271 ||| IN
UCBD  ||| S:271 E:276 ||| NNP
on  ||| S:276 E:279 ||| IN
recurrence  ||| S:279 E:290 ||| NN
and  ||| S:290 E:294 ||| CC
survival ||| S:294 E:302 ||| NN
.  ||| S:302 E:304 ||| .
We  ||| S:304 E:307 ||| PRP
reviewed  ||| S:307 E:316 ||| VBD
our  ||| S:316 E:320 ||| PRP$
institutional  ||| S:320 E:334 ||| JJ
database  ||| S:334 E:343 ||| NN
of  ||| S:343 E:346 ||| IN
patients  ||| S:346 E:355 ||| NNS
who  ||| S:355 E:359 ||| WP
underwent  ||| S:359 E:369 ||| VBD
RC  ||| S:369 E:372 ||| NNP
for  ||| S:372 E:376 ||| IN
UC  ||| S:376 E:379 ||| NNP
( ||| S:379 E:380 ||| -LRB-
1971-2009 ||| S:380 E:389 ||| NNP
) ||| S:389 E:390 ||| -RRB-
.  ||| S:390 E:392 ||| .
Outcomes  ||| S:392 E:401 ||| NNP
were  ||| S:401 E:406 ||| VBD
compared  ||| S:406 E:415 ||| VBN
between  ||| S:415 E:423 ||| IN
patients  ||| S:423 E:432 ||| NNS
with  ||| S:432 E:437 ||| IN
and  ||| S:437 E:441 ||| CC
without  ||| S:441 E:449 ||| IN
UCBD ||| S:449 E:453 ||| NNP
.  ||| S:453 E:455 ||| .
Kaplan-Meier  ||| S:455 E:468 ||| JJ
curves  ||| S:468 E:475 ||| NN
estimated  ||| S:475 E:485 ||| VBD
recurrence-free  ||| S:485 E:501 ||| JJ
survival  ||| S:501 E:510 ||| NN
( ||| S:510 E:511 ||| -LRB-
RFS ||| S:511 E:514 ||| NNP
)  ||| S:514 E:516 ||| -RRB-
and  ||| S:516 E:520 ||| CC
overall  ||| S:520 E:528 ||| JJ
survival  ||| S:528 E:537 ||| NN
( ||| S:537 E:538 ||| -LRB-
OS ||| S:538 E:540 ||| NNP
) ||| S:540 E:541 ||| -RRB-
.  ||| S:541 E:543 ||| .
Multivariable  ||| S:543 E:557 ||| NNP
Cox  ||| S:557 E:561 ||| NNP
regression  ||| S:561 E:572 ||| VBD
evaluated  ||| S:572 E:582 ||| VBN
associations  ||| S:582 E:595 ||| NNS
between  ||| S:595 E:603 ||| IN
UCBD  ||| S:603 E:608 ||| NNP
and  ||| S:608 E:612 ||| CC
survival ||| S:612 E:620 ||| NN
.  ||| S:620 E:622 ||| .
Inclusion  ||| S:622 E:632 ||| JJ
criteria  ||| S:632 E:641 ||| NNS
were  ||| S:641 E:646 ||| VBD
met  ||| S:646 E:650 ||| VBN
in  ||| S:650 E:653 ||| IN
1991  ||| S:653 E:658 ||| CD
patients ||| S:658 E:666 ||| NNS
.  ||| S:666 E:668 ||| .
UCBD  ||| S:668 E:673 ||| NNP
was  ||| S:673 E:677 ||| VBD
seen  ||| S:677 E:682 ||| VBN
in  ||| S:682 E:685 ||| IN
77  ||| S:685 E:688 ||| CD
( ||| S:688 E:689 ||| -LRB-
4  ||| S:689 E:691 ||| CD
% ||| S:691 E:692 ||| NN
)  ||| S:692 E:694 ||| -RRB-
patients  ||| S:694 E:703 ||| NNS
and  ||| S:703 E:707 ||| CC
occurred  ||| S:707 E:716 ||| VBD
exclusively  ||| S:716 E:728 ||| RB
in  ||| S:728 E:731 ||| IN
men  ||| S:731 E:735 ||| NNS
( ||| S:735 E:736 ||| -LRB-
mean  ||| S:736 E:741 ||| JJ
age  ||| S:741 E:745 ||| NN
68  ||| S:745 E:748 ||| CD
±  ||| S:748 E:750 ||| CD
8.5  ||| S:750 E:754 ||| CD
years ||| S:754 E:759 ||| NNS
) ||| S:759 E:760 ||| -RRB-
.  ||| S:760 E:762 ||| .
The  ||| S:762 E:766 ||| DT
highest  ||| S:766 E:774 ||| JJS
pathologic  ||| S:774 E:785 ||| JJ
stage  ||| S:785 E:791 ||| NN
tumor  ||| S:791 E:797 ||| NN
was  ||| S:797 E:801 ||| VBD
found  ||| S:801 E:807 ||| VBN
in  ||| S:807 E:810 ||| IN
the  ||| S:810 E:814 ||| DT
BD  ||| S:814 E:817 ||| NNP
in  ||| S:817 E:820 ||| IN
44  ||| S:820 E:823 ||| CD
( ||| S:823 E:824 ||| -LRB-
57  ||| S:824 E:827 ||| CD
% ||| S:827 E:828 ||| NN
)  ||| S:828 E:830 ||| -RRB-
of  ||| S:830 E:833 ||| IN
these  ||| S:833 E:839 ||| DT
patients ||| S:839 E:847 ||| NNS
.  ||| S:847 E:849 ||| .
Pathologic  ||| S:849 E:860 ||| JJ
upstaging  ||| S:860 E:870 ||| NN
was  ||| S:870 E:874 ||| VBD
more  ||| S:874 E:879 ||| RBR
common  ||| S:879 E:886 ||| JJ
with  ||| S:886 E:891 ||| IN
UCBD  ||| S:891 E:896 ||| NNP
compared  ||| S:896 E:905 ||| VBN
with  ||| S:905 E:910 ||| IN
UC  ||| S:910 E:913 ||| NNP
not  ||| S:913 E:917 ||| RB
in  ||| S:917 E:920 ||| IN
BD  ||| S:920 E:923 ||| NNP
( ||| S:923 E:924 ||| -LRB-
48  ||| S:924 E:927 ||| CD
vs.  ||| S:927 E:931 ||| IN
39  ||| S:931 E:934 ||| CD
% ||| S:934 E:935 ||| NN
,  ||| S:935 E:937 ||| ,
p  ||| S:937 E:939 ||| VBG
=  ||| S:939 E:941 ||| SYM
0.031 ||| S:941 E:946 ||| CD
) ||| S:946 E:947 ||| -RRB-
.  ||| S:947 E:949 ||| .
On  ||| S:949 E:952 ||| IN
univariate  ||| S:952 E:963 ||| JJ
analysis ||| S:963 E:971 ||| NN
,  ||| S:971 E:973 ||| ,
no  ||| S:973 E:976 ||| DT
differences  ||| S:976 E:988 ||| NNS
in  ||| S:988 E:991 ||| IN
RFS  ||| S:991 E:995 ||| NNP
or  ||| S:995 E:998 ||| CC
OS  ||| S:998 E:1001 ||| NNP
were  ||| S:1001 E:1006 ||| VBD
observed  ||| S:1006 E:1015 ||| VBN
comparing  ||| S:1015 E:1025 ||| VBG
patients  ||| S:1025 E:1034 ||| NNS
with  ||| S:1034 E:1039 ||| IN
or  ||| S:1039 E:1042 ||| CC
without  ||| S:1042 E:1050 ||| IN
UCBD  ||| S:1050 E:1055 ||| NNP
stratified  ||| S:1055 E:1066 ||| NN
by  ||| S:1066 E:1069 ||| IN
clinically  ||| S:1069 E:1080 ||| JJ
organ-confined  ||| S:1080 E:1095 ||| NN
( ||| S:1095 E:1096 ||| -LRB-
≤T2 ||| S:1096 E:1099 ||| NNP
)  ||| S:1099 E:1101 ||| -RRB-
and  ||| S:1101 E:1105 ||| CC
extravesical  ||| S:1105 E:1118 ||| NNS
( ||| S:1118 E:1119 ||| -LRB-
> ||| S:1119 E:1120 ||| NNP
T2 ||| S:1120 E:1122 ||| NNP
)  ||| S:1122 E:1124 ||| -RRB-
disease ||| S:1124 E:1131 ||| NN
.  ||| S:1131 E:1133 ||| .
On  ||| S:1133 E:1136 ||| IN
multivariable  ||| S:1136 E:1150 ||| JJ
analysis ||| S:1150 E:1158 ||| NN
,  ||| S:1158 E:1160 ||| ,
the  ||| S:1160 E:1164 ||| DT
presence  ||| S:1164 E:1173 ||| NN
of  ||| S:1173 E:1176 ||| IN
UCBD  ||| S:1176 E:1181 ||| NNP
was  ||| S:1181 E:1185 ||| VBD
not  ||| S:1185 E:1189 ||| RB
associated  ||| S:1189 E:1200 ||| VBN
with  ||| S:1200 E:1205 ||| IN
differences  ||| S:1205 E:1217 ||| NNS
in  ||| S:1217 E:1220 ||| IN
RFS  ||| S:1220 E:1224 ||| NNP
( ||| S:1224 E:1225 ||| -LRB-
HR  ||| S:1225 E:1228 ||| NNP
0.92 ||| S:1228 E:1232 ||| NNP
,  ||| S:1232 E:1234 ||| ,
95  ||| S:1234 E:1237 ||| CD
%  ||| S:1237 E:1239 ||| NN
CI  ||| S:1239 E:1242 ||| NNP
0.59-1.42 ||| S:1242 E:1251 ||| NNP
,  ||| S:1251 E:1253 ||| ,
p  ||| S:1253 E:1255 ||| VBG
=  ||| S:1255 E:1257 ||| SYM
0.69 ||| S:1257 E:1261 ||| CD
)  ||| S:1261 E:1263 ||| -RRB-
or  ||| S:1263 E:1266 ||| CC
OS  ||| S:1266 E:1269 ||| NNP
( ||| S:1269 E:1270 ||| -LRB-
HR  ||| S:1270 E:1273 ||| NNP
0.98 ||| S:1273 E:1277 ||| NNP
,  ||| S:1277 E:1279 ||| ,
95  ||| S:1279 E:1282 ||| CD
%  ||| S:1282 E:1284 ||| NN
CI  ||| S:1284 E:1287 ||| NNP
0.74-1.31 ||| S:1287 E:1296 ||| NNP
,  ||| S:1296 E:1298 ||| ,
p  ||| S:1298 E:1300 ||| VBG
=  ||| S:1300 E:1302 ||| SYM
0.92 ||| S:1302 E:1306 ||| CD
) ||| S:1306 E:1307 ||| -RRB-
.  ||| S:1307 E:1309 ||| .
Upstaging  ||| S:1309 E:1319 ||| NNP
was  ||| S:1319 E:1323 ||| VBD
common  ||| S:1323 E:1330 ||| JJ
in  ||| S:1330 E:1333 ||| IN
patients  ||| S:1333 E:1342 ||| NNS
with  ||| S:1342 E:1347 ||| IN
UCBD ||| S:1347 E:1351 ||| NNP
,  ||| S:1351 E:1353 ||| ,
observed  ||| S:1353 E:1362 ||| VBD
in  ||| S:1362 E:1365 ||| IN
almost  ||| S:1365 E:1372 ||| RB
half  ||| S:1372 E:1377 ||| NN
of  ||| S:1377 E:1380 ||| IN
the  ||| S:1380 E:1384 ||| DT
patients ||| S:1384 E:1392 ||| NNS
.  ||| S:1392 E:1394 ||| .
There  ||| S:1394 E:1400 ||| EX
were  ||| S:1400 E:1405 ||| VBD
no  ||| S:1405 E:1408 ||| DT
differences  ||| S:1408 E:1420 ||| NNS
in  ||| S:1420 E:1423 ||| IN
RFS  ||| S:1423 E:1427 ||| NNP
or  ||| S:1427 E:1430 ||| CC
OS  ||| S:1430 E:1433 ||| NNP
after  ||| S:1433 E:1439 ||| IN
RC  ||| S:1439 E:1442 ||| NNP
when  ||| S:1442 E:1447 ||| WRB
comparing  ||| S:1447 E:1457 ||| JJ
patients  ||| S:1457 E:1466 ||| NNS
with  ||| S:1466 E:1471 ||| IN
or  ||| S:1471 E:1474 ||| CC
without  ||| S:1474 E:1482 ||| IN
UC  ||| S:1482 E:1485 ||| NNP
in  ||| S:1485 E:1488 ||| IN
a  ||| S:1488 E:1490 ||| DT
diverticulum  ||| S:1490 E:1503 ||| JJ
stratified  ||| S:1503 E:1514 ||| NN
by  ||| S:1514 E:1517 ||| IN
stage ||| S:1517 E:1522 ||| NN
.  ||| S:1522 E:1524 ||| .
